Waters Parkerson & Co’s DarioHealth DRIO Stock Holding History

Waters Parkerson & Co’s Portfolio DRIO Stock Details DRIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-50	Closed	-$4K	–	173
2017 Q4	$4K	Buy	+50	New	+$33.9K	﹤0.01%	174

Other funds holding DRIO

Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

PVH

Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

MIM

Marco Investment Management Atlanta, Georgia $1.33B AUM 32.43% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Waters Parkerson & Co's DRIO Position: Q1 2018 in Review

Waters Parkerson & Co sold out of DarioHealth (DRIO) in Q1 2018, closing a stake of 50 shares — an estimated $4K sold.

Waters Parkerson & Co first reported a position in DRIO in Q4 2017 and held it in 1 quarter. The position peaked at $4K in Q4 2017. 12 funds tracked by Wall St. Rank hold DRIO as of Q1 2018.

Waters Parkerson & Co reported no remaining DarioHealth position as of Q1 2018 after selling out during the quarter.
Waters Parkerson & Co sold 50 DarioHealth shares in Q1 2018, an estimated $4K.
Waters Parkerson & Co first reported a position in DarioHealth in Q4 2017 and held it in 1 quarter.
Waters Parkerson & Co's DarioHealth position peaked at $4K in Q4 2017.
12 funds tracked by Wall St. Rank held DarioHealth as of Q1 2018.

Based on Waters Parkerson & Co's 13F filing for Q1 2018, filed 9 May 2018.